தொழில் முனைவோர் விரைவுபடுத்துதல் ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தொழில் முனைவோர் விரைவுபடுத்துதல் ப்ரோக்ர்யாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தொழில் முனைவோர் விரைவுபடுத்துதல் ப்ரோக்ர்யாம் Today - Breaking & Trending Today

Researchers devise new way to design clot-prone grafts for dialysis

Researchers devise new way to design clot-prone grafts for dialysis
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

United States , Eric Leuthardt , Dillon Williams , Mohamed Zayed , Louise Leuthardt , Emily Henderson , School Of Medicine , Louis Skandalaris Center Leadership , Society For Vascular Surgery Foundationm Zayed , National Institutes Of Health Heart , Washington University , Technology At Washington University In St , Technology Center , University Of Minnesota , Blood Institute , Entrepreneurship Acceleration Programm Zayed , Mckelvey School Of Engineering , National Science Foundation , Washington University School Of Medicine , American Surgical Association Foundationm Zayed , Washington University In St , Washington University School , Mckelvey School , Guy Genin , Faught Professor , Mechanical Engineering ,

Compound may prevent risk of form of arrhythmia from common medications | The Source

Multi-institutional team combined expertise to make discovery
May 17, 2021
SHARE
Dozens of commonly used drugs, including antibiotics, anti-nausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome. While safe in their current dosages, some of these drugs may have a more therapeutic benefit at higher doses, but are limited by the risk of arrhythmia.
Through both computational and experimental validation, a multi-institutional team of researchers has identified a compound that prevents the lengthening of the heart’s electrical event, or action potential, resulting in a major step toward safer use and expanded therapeutic efficacy of these medications when taken in combination. ....

Jianmin Cui , Mira Cohen , Xiaoqin Zou , Institute For Data Science , Skandalaris Center , Institute Of Clinical , Entrepreneurial Acceleration Program , Office Of Technology Management , Washington University Office Of Technology Management , Translational Sciences , University Of Missouri , Research Innovation In Biotechnology , Proceedings Of The National Academy Sciences , Dalton Cardiovascular Research Center , Washington University In St , Institute For Molecular Cardiology , National Academy , Mckelvey School , Washington University , Distinguished Professor , Molecular Cardiology , Renaissance School , Stony Brook University , Data Science , Washington University Office , Technology Management ,

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs
Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome. While safe in their current dosages, some of these drugs may have a more therapeutic benefit at higher doses, but are limited by the risk of arrhythmia.
Through both computational and experimental validation, a multi-institutional team of researchers has identified a compound that prevents the lengthening of the heart s electrical event, or action potential, resulting in a major step toward safer use and expanded therapeutic efficacy of these medications when taken in combination. The team found that the compound, named C28, not only prevents or reverses the negative physiological effects on the action potential, ....

Jianmin Cui , Mira Cohen , Xiaoqin Zou , Emily Henderson , Institute For Data Science , Skandalaris Center , Office Of Technology Management , Institute Of Clinical , Entrepreneurial Acceleration Program , Washington University Office Of Technology Management , Translational Sciences , University Of Missouri , Research Innovation In Biotechnology , Proceedings Of The National Academy Sciences , Dalton Cardiovascular Research Center , Washington University In St , Institute For Molecular Cardiology , National Academy , Mckelvey School , Washington University , Distinguished Professor , Molecular Cardiology , Renaissance School , Stony Brook University , Data Science , Washington University Office ,

Compound may prevent risk of a form of arrhythmia from common medications

E-Mail
IMAGE: Xiaoqin Zou, professor of physics, biochemistry, and a member of the Dalton Cardiovascular Research Center and Institute for Data Science and Informatics at the University of Missouri
view more
Credit: University of Missouri
Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome. While safe in their current dosages, some of these drugs may have a more therapeutic benefit at higher doses, but are limited by the risk of arrhythmia.
Through both computational and experimental validation, a multi-institutional team of researchers has identified a compound that prevents the lengthening of the heart s electrical event, or action potential, resulting in a major step toward safer use and expanded therapeutic efficacy of these med ....

Jianmin Cui , Mira Cohen , Xiaoqin Zou , Institute For Data Science , Skandalaris Center , Institute Of Clinical , Entrepreneurial Acceleration Program , Office Of Technology Management , Washington University Office Of Technology Management , Translational Sciences , University Of Missouri , Research Innovation In Biotechnology , Proceedings Of The National Academy Sciences , Dalton Cardiovascular Research Center , Washington University In St , Institute For Molecular Cardiology , National Academy , Mckelvey School , Washington University , Distinguished Professor , Molecular Cardiology , Renaissance School , Stony Brook University , Data Science , Washington University Office , Technology Management ,

Allman, Solnica-Krezel receive faculty achievement awards | The Source | Washington University in St. Louis

DiAntonio, Milbrandt honored for innovation, entrepreneurship
May 7, 2021
SHARE
Jean Allman and Lilianna Solnica-Krezel will receive Washington University in St. Louis’ 2021 faculty achievement awards, Chancellor Andrew D. Martin announced.
Allman, PhD, the J.H. Hexter Professor in the Humanities and professor of African and African American studies, as well as director of the Center for the Humanities, all in Arts & Sciences, will receive the Arthur Holly Compton Faculty Achievement Award. Solnica-Krezel, PhD, the Alan A. and Edith L. Wolff Distinguished Professor and head of the Department of Developmental Biology at the School of Medicine, will receive the Carl and Gerty Cori Faculty Achievement Award. ....

United States , Northern Cape , South Africa , Stanford University , United Kingdom , Jamess Mcdonnell , Andrewd Martin , Jeffrey Milbrandt , Eli Lilly , Edithl Wolff , Bruce Lindsey , Lila Solnica Krezel , Jean Allman , Arthur Holly Compton , Aaron Diantonio , Lilianna Solnica Krezel , Ohio University , Mellon Foundation , Department Of Developmental Biology , International Journal Of African Historical , National Endowment For The Humanities , Cambridge University , International Zebrafish Society , Warsaw University , Washington University In St , University Of California ,